The number of patients with cardiac implantable electronic devices (CIEDs) constantly increases and due to growing incidence of cancer, many of them will require an anticancer treatment. At least a half of patients treated for malignant neoplasms, apart from other treatment methods, require radiotherapy. Although papers presenting the results of in vitro studies provide clues on the susceptibility of CIEDs to ionizing radiation, the research methods used often stand out from typical clinical situations.
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IntroductIon
Systematically growing population of patients with cardiac implantable electronic devices (CIEDs) and increasing incidence and prevalence of cancer make the patients with CIEDs more and more commonly seen recipients of anticancer treatment and at least a half of them is expected to require radiotherapy [1, 2] .
Although the susceptibility of the cardiac implantable electronic devices to ionizing radiation is systematically tested since many years, the conclusions from the in vitro studies are not obvious. First, the technology systematically changes and the CIEDs gain new functionalities and programming options. New models are introduced which makes prior assessments unreliable and difficult to apply to new and untested devices. New generations of pacemakers (PMs) and implantable cardioverters-defibrillators (ICDs) emerge on the market, including those with novel conception of heart stimulation, like subcutaneous devices which do not require intravenous leads or leadless intracardiac pacing systems [3, 4] . Additionally, new devices used for different than before purposes are becoming popular. Cardiac resynchronization therapy devices (CRT) with or without the ICD function (CRT-D, and CRT-P, respectively) have already a well-established position in the armamentarium of treatment methods used in congestive heart failure [5] . Although the role of CRT devices is not questioned in contemporary cardiology, little is known about their susceptibility to radiation and it is hard to define what way they should be treated like. Due to their predominantly stimulating function, potentially similar precautions to those used in case of PMs could be applied.
When they have also an ICD function, a question can be raised if patients with CRT-D should be treated in a similar way to patients with ICDs, or rather specific treatment algorithms should be elaborated.
Moreover, apart from the dynamic changes in the construction of the CIEDs, also recent advances in the radiotherapy technique contribute to the fact that the results of studies on cardiac implantable electronic devices in patients subject to radiotherapy rapidly become obsolete. Relatively new dynamic techniques, like volumetric modulated arc therapy (VMAT), tomotherapy or respiratory gating quickly became a standard in the clinic because of the advancements in dose distribution and sparing critical organs from high doses of radiation they offer. At the same time, utilization of such techniques is inevitably associated with increased volumes of low and very low doses delivered in large volumes of the patient's body which can translate into larger dose deposited in the cardiac devices [6] .
The susceptibility of CIEDs to ionizing radiation is confirmed in several clinical studies. Until recent years, most of the reports on device malfunctions were found in case reports or small case series. The dose delivered to the CIEDs associated with device malfunction varies widely and a number of potential predictive factors for failure were proposed, of which, radiation energy, prescribed dose and location of the irradiated target volume play the major role [7] [8] [9] .
consIderAtIons on the results of In vItro studIes
Many in vitro studies indicate that radiotherapy can negatively influence the operation of the CIEDs. There are, however, some examples of studies potentially indicating that the current dose limits for CIEDs are too restrictive because the currently used devices can withstand more dose than models used previously [10] .
Closer look at the methods used to prove this assumption reveals that the study setup does not resemble the clinical conditions seen during typical radiotherapy sessions. The commonly used guidelines preclude direct irradiation of the devices [11] [12] [13] [14] .
Moreover, the planned dose during radiotherapy in case of conventional treatment is delivered in several fractions which results with a 5-8 weeks long treatment. It is widely accepted that the damaging effects of even low radiation doses are accumulative and the probability of occurrence of a malfunction is also a function of the length of the treatment, apart from the dose deposited in the generator and energy of the radiation used [8] . Thus, to reliable test the CIEDs in clinical-like conditions it is advisable to prepare and execute the treatment plan in the same way it is carried-out in the clinic. It makes such an in vitro study more complicated and time-and resource-consuming but the results should be more reliable and more easily applicable in appropriate clinical conditions.
clInIcAl experIence wIth rAdIotherApy In pAtIents wIth cIeds
In vivo data published in recent years indicate that the problem of CIED malfunction in patients subject to radiation therapy can involve as many as 7% of the patients with implanted devices irradiated for various types of cancer [7, 8] . Interestingly, one of the predictors of CIED malfunction was the body region which was irradiated, with higher risk in patients irradiated for abdominal and pelvic tumors. As in these patients more often high energy, neutron-producing radiation is used, this observation would not be surprising, but when the analysis was limited only to cases in which neutron-producing radiation was used, the location Radiotherapy in patients with cardiac implantable electronic devices -clinical experience S. Blamek A www.oncoreview.pl of the target volume remained a significant predictive factor for CIED malfunction [7] . The authors described 249 radiation therapy courses in 215 patients. The cumulative dose to CIEDs varied between 0.002 and 3.2 Gy. In 3 patients it was not estimated. In patients irradiated with electrons only, no device upsets were recorded [7] . Bagur et al. also described a relatively large cohort (230) of irradiated patients with CIEDs. Although detailed information on the cardiac devices and comorbidities was provided, neither information on radiation energy nor on dose to the pulse generator were recorded. In no case, however, the device was exposed to direct radiation [8] . In 9% (21 patients) device relocation prior to radiotherapy was performed to minimize the risk of radiation exposure. Interestingly, device failure was observed more often in patients after relocation of the generator.
Also shorter device age was associated with higher probability of malfunction. The multivariate analysis showed, however, that the only independent factor associated with CIED malfunction was the total dose prescribed to the tumor [8] . Due to the lack of details concerning radiotherapy, a possible association between CIED malfunction and energy of the ionizing radiation was not ter [15] . Of that number, only in 4 devices malfunctions were recorded. In one patient a device power-on reset occurred, the remaining 3 experienced ventricular pacing at maximum sensor rate which was, however, well tolerated [15] . Notably, in all but 3 patients the estimated dose to the CIED was below 2 Gy, in one the measured dose was 3 Gy. In 9 patients CIED relocation was made.
On the other hand, in patients irradiated solely with neutron-producing radiation, the percentage of malfunctions can be even higher than the 7% estimated for the whole population of irradiated patients with CIEDs. Elders et al. reported on 15 patients with ICDs subjected to 17 courses of radiotherapy [9] . In this relatively small group, in 5 patients (29% of radiation therapy courses) malfunctions were registered. In additional one patient a late data error was encountered during interrogation which in total adds up to 35% of the 17 radiotherapy courses while others did not report such kind of dysfunction at all [7, 15] .
The critical failures, requiring acute replacement of the generator are rare. In general, most of the detected malfunctions were correctable by reprogramming. It should be noted, however, that it is not a rule and 2 unrecoverable resets requiring replacement of the compromised device, although uncommon, were also described (tab. 1) [7] . A potentially lethal event of inappropriate pacing resulting with triggering ventricular tachyarrhythmia (VT) was described by Nemec et al. The device was a one-chamber ICD placed for primary prophylaxis of sudden cardiac death. During irradiation for lung cancer (left upper lobe), the patient collapsed and required on-site cardiopulmonary resuscitation resulting with reappearance of the sinus rhythm. The device was interrogated but no malfunction was detected. The manufacturer also examined the device and suggested that inappropriate pacing which, as a result, triggered VT could be a result of change of the content of random access memory caused by ionizing radiation [19] .
The reported CIED malfunction rate during radiotherapy oscillates in wide range and in most cases the detected failures are A number of national guidelines, reviews and recommendations concerning radiotherapy in patients with CIEDs were published to date [11] [12] [13] [14] [22] [23] [24] . Although the standards of treatment proposed in these papers are similar, still many discrepancies can be seen, especially concerning the schedule and need for monitoring and systematic interrogation of the devices during treatment. Moreover, recommendations concerning patients with CRT devices are rare and the amount of in vitro and clinical data being the groundwork for formulation of specific guidelines is still very limited. There is also no agreement on handling the CIEDs after radiotherapy. Some authors suggest that a CIED irradiated with doses greater than 5 Gy during the whole treatment course should be replaced after completion of the therapy [25] .
However, there is a risk of manifestation of a damage even after a treatment with cumulative dose deposited in the generator being below this limit, as described by Elders et al. in a patient treated with 18 MV photons. The device reset trend data error was recorded 9 months after the treatment but the causative role of radiotherapy could not be proven [9] .
Following the practice in other centers, as well as recommendations formulated by the Polish Society of Radiation Oncology and other national scientific societies, with special respect to the latest DEGRO/DGK guidelines, an internal procedure of the management of patients with CIEDs subjected to radiotherapy in the author's center was introduced. The safety measures taken are briefly summarized in table 2 and in full detail are available in the referenced papers [11, 26] . 
